{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:12:54Z","timestamp":1790140374649,"version":"4.0.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jbo.2020.100282","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T22:52:11Z","timestamp":1582066331000},"page":"100282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Bone metastases in thyroid cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Nicole M.","family":"I\u00f1iguez-Ariza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Bible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2020.100282_bib0001","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/thy.2000.10.261","article-title":"Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients","volume":"10","author":"Pittas","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0003","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2016-3906","article-title":"Skeletal complications and mortality in thyroid cancer: a population-based study","volume":"102","author":"Choksi","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0004","first-page":"305","author":"Hay ID","year":"1988"},{"key":"10.1016\/j.jbo.2020.100282_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/thy.2018.0582","article-title":"Improved survival after multimodal approach with (131)I treatment in patients with bone metastases secondary to differentiated thyroid cancer","volume":"29","author":"Wu","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000494719","article-title":"Bone metastases from thyroid carcinoma of follicular origin: a single institutional experience","volume":"8","author":"Matta-Coelho","year":"2019","journal-title":"Eur. Thyroid. J."},{"key":"10.1016\/j.jbo.2020.100282_bib0007","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jcem.86.4.7390","article-title":"Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas","volume":"86","author":"Bernier","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0008","first-page":"377","article-title":"Papillary and follicular thyroid carcinomas with bone metastases: a series of 39 cases during a period of 18 years","volume":"21","author":"Fanchiang","year":"1998","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"10.1016\/j.jbo.2020.100282_bib0009","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/thy.1999.9.1227","article-title":"Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases","volume":"9","author":"Lin","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0010","first-page":"960","article-title":"Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma","volume":"106","author":"Marcocci","year":"1989","journal-title":"Surgery"},{"key":"10.1016\/j.jbo.2020.100282_bib0011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/ERC-07-0229","article-title":"Bone metastases from differentiated thyroid carcinoma","volume":"15","author":"Muresan","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0012","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF02067343","article-title":"Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?","volume":"16","author":"Proye","year":"1992","journal-title":"World J. Surg."},{"key":"10.1016\/j.jbo.2020.100282_bib0013","first-page":"598","article-title":"Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma","volume":"37","author":"Schlumberger","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0014","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1210\/jc.2016-2815","article-title":"Bone metastases and skeletal-related events in medullary thyroid carcinoma","volume":"101","author":"Xu","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0015","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1089\/thy.2013.0633","article-title":"Spinal metastases due to thyroid carcinoma: an analysis of 202 patients","volume":"24","author":"Kushchayeva","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0016","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/jc.2012-1169","article-title":"Skeletal-related events due to bone metastases from differentiated thyroid cancer","volume":"97","author":"Farooki","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0017","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tips.2015.04.001","article-title":"The emerging molecular machinery and therapeutic targets of metastasis","volume":"36","author":"Sun","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbo.2020.100282_bib0018","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1158\/0008-5472.CAN-07-1653","article-title":"Adaptation versus selection: the origins of metastatic behavior","volume":"67","author":"Scheel","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0019","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2020.100282_bib0021","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","article-title":"Hypoxia and hypoxia-inducible factors: master regulators of metastasis","volume":"16","author":"Lu","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF02409059","article-title":"Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer","volume":"3","author":"Owens","year":"1996","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0023","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ecl.2007.04.005","article-title":"Thyroid and bone","volume":"36","author":"Wexler","year":"2007","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jbo.2020.100282_bib0024","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1541-7786.MCR-16-0007","article-title":"FAK expression, not kinase activity, is a key mediator of thyroid tumorigenesis and pro-tumorigenic processes","volume":"14","author":"Kessler","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/10507250150500658","article-title":"Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array","volume":"11","author":"Chen","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0026","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1096\/fj.01-0911fje","article-title":"Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone","volume":"16","author":"Pecheur","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jbo.2020.100282_bib0027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coph.2015.04.004","article-title":"Emerging therapies in bone metastasis","volume":"22","author":"Clement-Demange","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jbo.2020.100282_bib0028","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/jnci\/djs263","article-title":"Effects of bone-targeted agents on cancer progression and mortality","volume":"104","author":"Coleman","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbo.2020.100282_bib0029","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","article-title":"Endocrine aspects of bone metastases","volume":"2","author":"Hofbauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jbo.2020.100282_bib0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"Suva","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbo.2020.100282_bib0031","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/276726a0","article-title":"Direct resorption of bone by human breast cancer cells in vitro","volume":"276","author":"Eilon","year":"1978","journal-title":"Nature"},{"issue":"Pt 3","key":"10.1016\/j.jbo.2020.100282_bib0032","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1242\/jcs.101.3.681","article-title":"Tumour infiltrating macrophages are capable of bone resorption","volume":"101","author":"Quinn","year":"1992","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.jbo.2020.100282_bib0033","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4158\/EP-2018-0465","article-title":"Long-Term outcomes and prognostic factors in patients with differentiated thyroid carcinoma and bone metastases","volume":"25","author":"Slook","year":"2019","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.jbo.2020.100282_bib0034","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/1097-0142(20000615)88:12+<2912::AID-CNCR6>3.0.CO;2-8","article-title":"Pathophysiologic interactions in skeletal metastasis","volume":"88","author":"Orr","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0035","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-Mutant anaplastic thyroid cancer","volume":"36","author":"Subbiah","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0037","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrclinonc.2016.19","article-title":"Evolving molecularly targeted therapies for advanced-stage thyroid cancers","volume":"13","author":"Bible","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0038","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ctrv.2015.06.002","article-title":"Targeted therapies in advanced differentiated thyroid cancer","volume":"41","author":"Carneiro","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbo.2020.100282_bib0039","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CAD.0000000000000247","article-title":"New insights in the treatment of radioiodine refractory differentiated thyroid carcinomas: to lenvatinib and beyond","volume":"26","author":"Wang","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jbo.2020.100282_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1210\/jcem.86.2.7226","article-title":"Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma","volume":"86","author":"Klein","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0041","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/msy.2001.112592","article-title":"Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer","volume":"129","author":"Lennard","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.jbo.2020.100282_bib0042","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1158\/1078-0432.CCR-05-0646","article-title":"Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases","volume":"11","author":"Yu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0043","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2020.100282_bib0044","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrclinonc.2014.193","article-title":"Genetics: the cancer genome atlas maps papillary thyroid cancer","volume":"11","author":"Killock","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbo.2020.100282_bib0046","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.critrevonc.2005.03.011","article-title":"Management of bone metastases in cancer: a review","volume":"56","author":"Selvaggi","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jbo.2020.100282_bib0047","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00330-006-0361-8","article-title":"Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT","volume":"17","author":"Schmidt","year":"2007","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0048","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","article-title":"Diagnosis of bone metastases: a meta-analysis comparing (1)(8)FDG PET, CT, MRI and bone scintigraphy","volume":"21","author":"Yang","year":"2011","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0049","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00256-004-0872-9","article-title":"Distinguishing stress fractures from pathologic fractures: a multimodality approach","volume":"34","author":"Fayad","year":"2005","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1148\/radiology.172.1.2740506","article-title":"Vertebral compression fractures: distinction between benign and malignant causes with MR imaging","volume":"172","author":"Yuh","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.jbo.2020.100282_bib0051","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1102\/1470-7330.2003.0029","article-title":"MRI of bone metastases: the choice of the sequence","volume":"4","author":"Vanel","year":"2004","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.jbo.2020.100282_bib0052","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2967\/jnumed.106.039479","article-title":"Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer","volume":"48","author":"Ito","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0053","first-page":"27","article-title":"Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions","volume":"45","author":"Savelli","year":"2001","journal-title":"Q. J. Nucl. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0054","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00003072-199906000-00006","article-title":"The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine","volume":"24","author":"Sedonja","year":"1999","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00259-002-0781-x","article-title":"Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer","volume":"29","author":"de Geus-Oei","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jbo.2020.100282_bib0056","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/105072501750362754","article-title":"Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography","volume":"11","author":"Schirrmeister","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0057","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00330-004-2350-0","article-title":"Value of (124)I-PET\/CT in staging of patients with differentiated thyroid cancer","volume":"14","author":"Freudenberg","year":"2004","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0058","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2003-031027","article-title":"Recombinant human thyrotropin stimulation of fluoro-d-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma","volume":"89","author":"Chin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.jbo.2020.100282_bib0059","first-page":"6","article-title":"Evaluation of impending fractures and indications for prophylactic fixation of metastases in long bones. Review of the literature","volume":"59","author":"Haentjens","year":"1993","journal-title":"Acta Orthop. Belgica"},{"key":"10.1016\/j.jbo.2020.100282_bib0060","article-title":"Surgical management of appendicular skeletal metastases in thyroid carcinoma","volume":"2012","author":"Satcher","year":"2012","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0061","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jbo.2020.100282_bib0062","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2265.2000.00998.x","article-title":"Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma","volume":"52","author":"Van Tol","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jbo.2020.100282_bib0063","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/thy.2000.10.621","article-title":"Images in thyroidology. Embolization of a bone metastasis of follicular thyroid carcinoma","volume":"10","author":"van Tol","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0064","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1210\/jc.2003-030231","article-title":"Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma","volume":"88","author":"Eustatia-Rutten","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ejso.2015.05.010","article-title":"Interventional radiologist\u2019s perspective on the management of bone metastatic disease","volume":"41","author":"Cazzato","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0066","article-title":"American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"2015","author":"Haugen","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0067","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.ejso.2015.06.005","article-title":"Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer","volume":"41","author":"Cazzato","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0068","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jvir.2014.08.011","article-title":"Cryoablation of sternal metastases for pain palliation and local tumor control","volume":"25","author":"Hegg","year":"2014","journal-title":"J. Vasc. Intervent. Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0069","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00330-014-3202-1","article-title":"Thermal ablation techniques: a curative treatment of bone metastases in selected patients?","volume":"24","author":"Deschamps","year":"2014","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow","year":"2012","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0071","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0030-6665(20)31272-X","article-title":"Radioiodine and radiotherapy in the management of thyroid cancers","volume":"23","author":"Simpson","year":"1990","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.jbo.2020.100282_bib0072","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/BF00353775","article-title":"Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine","volume":"18","author":"Pacini","year":"1994","journal-title":"World J. Surg."},{"key":"10.1016\/j.jbo.2020.100282_bib0073","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1210\/jc.2011-0093","article-title":"Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer","volume":"96","author":"Qiu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0074","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12020-017-1455-6","article-title":"Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience","volume":"59","author":"Mazziotti","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.jbo.2020.100282_bib0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1209288","article-title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","volume":"368","author":"Ho","year":"2013","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0076","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJM197401242900404","article-title":"Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients","volume":"290","author":"Gottlieb","year":"1974","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0077","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E","article-title":"A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma","volume":"56","author":"Shimaoka","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0078","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/030089169007600513","article-title":"Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy","volume":"76","author":"Droz","year":"1990","journal-title":"Tumori"},{"key":"10.1016\/j.jbo.2020.100282_bib0079","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s12032-011-0070-2","article-title":"GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma","volume":"29","author":"Spano","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0080","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(05)70206-0","article-title":"Radioisotopes for the palliation of metastatic bone cancer: a systematic review","volume":"6","author":"Finlay","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0081","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1158\/1078-0432.CCR-04-2244","article-title":"First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases","volume":"11","author":"Nilsson","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0082","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0083","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00001813-200501000-00002","article-title":"Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumor cell invasion","volume":"16","author":"Woodward","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jbo.2020.100282_bib0084","first-page":"1617","article-title":"Effects of clodronate on cancer growth and Ca2+ signaling of human thyroid carcinoma cell lines","volume":"24","author":"Yang","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbo.2020.100282_bib0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1634\/theoncologist.2012-0261","article-title":"Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis","volume":"18","author":"Valachis","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jbo.2020.100282_bib0086","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(15)60908-4","article-title":"Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jbo.2020.100282_bib0087","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jbo.2020.100282_bib0088","first-page":"679","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0089","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0090","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","article-title":"Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial","volume":"23","author":"Kohno","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0091","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0092","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0093","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0094","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1054\/bjoc.2001.1832","article-title":"Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer","volume":"84","author":"Vitale","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/thy.2010.0169","article-title":"Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma","volume":"21","author":"Orita","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0096","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-015-4497-0","article-title":"Prospective evaluation of zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma","author":"Orita","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0097","series-title":"Medullary Thyroid Cancer with Bone Metastases and the Effect of Antiresorptive Agents on Skeletal Related Events: Experience at MD Anderson Cancer Center Endocrine Society's 98th Annual Meeting and Expo; April 3, 2016","author":"Xu JY","year":"2016"},{"key":"10.1016\/j.jbo.2020.100282_bib0098","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jbo.2020.100282_bib0099","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"93","author":"Puhaindran","year":"2011","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.jbo.2020.100282_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","article-title":"Medication-related osteonecrosis of the jaw: an update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention","volume":"125","author":"Owosho","year":"2018","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol."},{"key":"10.1016\/j.jbo.2020.100282_bib0101","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.bbrc.2013.12.076","article-title":"Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation","volume":"443","author":"Chu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbo.2020.100282_bib0102","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2014-2811","article-title":"Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat\u2013and with which drug\u2013those are the questions","volume":"99","author":"Cabanillas","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0103","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jbo.2020.100282_bib0106","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbo.2020.100282_bib0107","series-title":"85th Annual Meeting of the American Thyroid Association","article-title":"Cabozantinib in patients with radioiodine-refractory differentiated thyroid cancer who progressed on prior VEGFR-targeted therapy: results of NCI- and ITOG-sponsored multicenter phase II clinical trial","author":"Shah MH","year":"2015"},{"key":"10.1016\/j.jbo.2020.100282_bib0108","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/jc.2009-1923","article-title":"Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience","volume":"95","author":"Cabanillas","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2020.100282_bib0109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised Recist guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0110","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bjc.1977.42","article-title":"Assessment of response to therapy in advanced breast cancer","volume":"35","author":"Hayward","year":"1977","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/bjc.1978.182","article-title":"Assessment of response to therapy in advanced breast cancer (an amendment)","volume":"38","author":"Hayward","year":"1978","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbo.2020.100282_bib0113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12020-017-1321-6","article-title":"\u201cPseudo-progression\u201d in advanced thyroid cancer in response to kinase inhibitor therapy","volume":"57","author":"Jasim","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.jbo.2020.100282_bib0114","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-16-0237","article-title":"Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma","author":"Choi","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbo.2020.100282_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1536-1632(03)00036-2","article-title":"Comparison of bone and 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in the evaluation of bony metastases in lung cancer","volume":"5","author":"Gayed","year":"2003","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.jbo.2020.100282_bib0116","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/radiology.212.3.r99se21803","article-title":"Staging non-small cell lung cancer with whole-body PET","volume":"212","author":"Marom","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.jbo.2020.100282_bib0117","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00432-002-0342-5","article-title":"Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99\u00a0m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer","volume":"128","author":"Yang","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0118","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/02841860310014895","article-title":"A systematic overview of radiation therapy effects in skeletal metastases","volume":"42","author":"Falkmer","year":"2003","journal-title":"Acta Oncol."},{"key":"10.1016\/j.jbo.2020.100282_bib0119","doi-asserted-by":"crossref","unstructured":"Frassica D.A.General principles of external beam radiation therapy for skeletal metastases. Clin. Orthop. Relat. Res. 2003:S158\u2013164.","DOI":"10.1097\/01.blo.0000093057.96273.fb"},{"key":"10.1016\/j.jbo.2020.100282_bib0120","article-title":"The role of radiotherapy in bone metastases: a critical review of current literature","author":"Kougioumtzopoulou","year":"2017","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.jbo.2020.100282_bib0121","first-page":"106","article-title":"Radiosurgery for spinal malignant tumors","volume":"106","author":"Wowra","year":"2009","journal-title":"Dtsch. Arztebl. Int."},{"issue":"Suppl:91\u2013101","key":"10.1016\/j.jbo.2020.100282_bib0122","article-title":"Calvarial and skull base metastases: expanding the clinical utility of gamma knife surgery","volume":"121","author":"Kotecha","year":"2014","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jbo.2020.100282_bib0123","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1120\/jacmp.v16i6.5618","article-title":"Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study","volume":"16","author":"Rief","year":"2015","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.jbo.2020.100282_bib0124","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0033-1353480","article-title":"Interventional management of vertebral body metastases","volume":"30","author":"Prince","year":"2013","journal-title":"Semin. Intervent. Radiol."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137419302131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137419302131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:17:24Z","timestamp":1761941844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137419302131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":124,"alternative-id":["S2212137419302131"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100282","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metastases in thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100282"}}